氢化可的松、维生素C与硫胺素治疗严重脓毒症和脓毒性休克:一项回顾性前后对照研究
这项回顾性前后对照研究在ICU中比较了连续收治的脓毒症患者,治疗组在7个月内接受静脉维生素C、氢化可的松和硫胺素,对照组为前7个月按常规治疗的患者。两组各47例,基线特征无显著差异。治疗组住院死亡率为8.5%(4/47),对照组为40.4%(19/47),P<.001;倾向评分校正后的死亡比值比为0.13(95%CI 0.04-0.48,P=.002)。治疗组所有患者SOFA评分均下降,无进展性器官衰竭,全部停用血管加压药,平均停药时间18.3±9.8小时,对照组血管加压药平均使用54.9±28.4小时(P<.001)。作者认为早期静脉使用维生素C联合糖皮质激素和硫胺素可能有效预防进行性器官功能障碍(包括急性肾损伤)并降低死亡率,但需进一步研究证实这些初步发现。
要点
- 治疗组住院死亡率8.5%(4/47) vs 对照组40.4%(19/47),P<.001。
- 倾向评分校正后死亡比值比0.13(95%CI 0.04-0.48,P=.002)。
- 治疗组全部停用血管加压药,平均18.3±9.8小时;对照组平均54.9±28.4小时(P<.001)。
- 治疗组SOFA评分均下降,无患者出现进展性器官衰竭。
- 作者认为早期静脉维生素C联合糖皮质激素和硫胺素可能有效,但需进一步研究证实。
适用人群与场景
- 连续收治的严重脓毒症和脓毒性休克患者,在ICU接受治疗。
- 治疗组为7个月期间连续收治的患者,对照组为前7个月在本ICU治疗的患者。
处置流程与药物剂量
- 治疗组接受静脉维生素C、氢化可的松和硫胺素联合方案;原文未写明具体剂量、给药频次和疗程。
- 对照组接受常规治疗;原文未写明具体方案。
研究设计与关键结果
- 研究类型为回顾性前后对照临床研究,治疗组和对照组各47例。
- 主要终点为住院生存率;治疗组住院死亡率8.5%(4/47) vs 对照组40.4%(19/47),P<.001。
- 倾向评分校正后,接受维生素C方案治疗的患者死亡比值比为0.13(95%CI 0.04-0.48,P=.002)。
- 治疗组所有患者SOFA评分均下降,无患者出现进展性器官衰竭。
- 治疗组全部患者停用血管加压药,平均停药时间18.3±9.8小时;对照组血管加压药平均使用时间54.9±28.4小时(P<.001)。
证据类型、等级与局限
- 证据类型:回顾性前后对照临床研究。
- 局限:原文未报告局限性;作者在结论中指出需额外研究证实这些初步发现。
对床旁实践的改变
- 作者认为,早期静脉使用维生素C联合糖皮质激素和硫胺素可能有效预防严重脓毒症和脓毒性休克患者的进行性器官功能障碍(包括急性肾损伤)并降低死亡率。
- 原文结论强调这些为初步发现,需额外研究证实。
- 原文未给出具体药物剂量、给药频次和疗程,无法据此形成床旁给药方案。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The global burden of sepsis is estimated as 15 to 19 million cases annually, with a mortality rate approaching 60% in low-income countries.
METHODS: In this retrospective before-after clinical study, we compared the outcome and clinical course of consecutive septic patients treated with intravenous vitamin C, hydrocortisone, and thiamine during a 7-month period (treatment group) with a control group treated in our ICU during the preceding 7 months. The primary outcome was hospital survival. A propensity score was generated to adjust the primary outcome.
RESULTS: There were 47 patients in both treatment and control groups, with no significant differences in baseline characteristics between the two groups. The hospital mortality was 8.5% (4 of 47) in the treatment group compared with 40.4% (19 of 47) in the control group (P < .001). The propensity adjusted odds of mortality in the patients treated with the vitamin C protocol was 0.13 (95% CI, 0.04-0.48; P = .002). The Sepsis-Related Organ Failure Assessment score decreased in all patients in the treatment group, with none developing progressive organ failure. All patients in the treatment group were weaned off vasopressors, a mean of 18.3 ± 9.8 h after starting treatment with the vitamin C protocol. The mean duration of vasopressor use was 54.9 ± 28.4 h in the control group (P < .001).
CONCLUSIONS: Our results suggest that the early use of intravenous vitamin C, together with corticosteroids and thiamine, are effective in preventing progressive organ dysfunction, including acute kidney injury, and in reducing the mortality of patients with severe sepsis and septic shock. Additional studies are required to confirm these preliminary findings.
参考来源
- Marik PE, Khangoora V, Rivera R, et al. Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study. Chest. 2016. PMID: 27940189. doi:10.1016/j.chest.2016.11.036
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。